KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verisign (VRSN) Research & Development (2016 - 2025)

Historic Research & Development for Verisign (VRSN) over the last 17 years, with Q3 2025 value amounting to $25.4 million.

  • Verisign's Research & Development rose 948.28% to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.0 million, marking a year-over-year increase of 770.86%. This contributed to the annual value of $96.7 million for FY2024, which is 626.37% up from last year.
  • According to the latest figures from Q3 2025, Verisign's Research & Development is $25.4 million, which was up 948.28% from $25.7 million recorded in Q2 2025.
  • In the past 5 years, Verisign's Research & Development ranged from a high of $26.0 million in Q1 2025 and a low of $19.6 million during Q3 2021
  • Over the past 5 years, Verisign's median Research & Development value was $22.9 million (recorded in 2022), while the average stood at $22.7 million.
  • Over the last 5 years, Verisign's Research & Development had its largest YoY gain of 1694.9% in 2021, and its largest YoY loss of 54.8% in 2021.
  • Quarter analysis of 5 years shows Verisign's Research & Development stood at $20.8 million in 2021, then grew by 3.37% to $21.5 million in 2022, then increased by 6.51% to $22.9 million in 2023, then increased by 8.73% to $24.9 million in 2024, then grew by 2.01% to $25.4 million in 2025.
  • Its Research & Development was $25.4 million in Q3 2025, compared to $25.7 million in Q2 2025 and $26.0 million in Q1 2025.